VHL: Trends and Insight into a Multi-Modality, Interdisciplinary Approach for Management of Central Nervous System Hemangioblastoma

Acta Neurochir Suppl. 2023:135:81-88. doi: 10.1007/978-3-031-36084-8_14.


Von Hippel-Lindau (VHL) is a multi-system disease which results in significant morbidity from central nervous system (CNS) involvement as well as ocular, renal and neuro-endocrine effects. Haemangioblastomas of the CNS present a number of challenges. The natural history of these lesions is varied, as is the size and location within the CNS. Whilst surgery is considered the mainstay of treatment and best chance at curing these lesions, this is also often associated with significant risks due to the anatomical location of these lesions, most commonly the posterior fossa and spinal cord.We review the literature and describe our experience across two separate European VHL referral centres. Alternative treatment options and combined modalities are increasingly being used in the context of managing CNS haemangioblastomas. We analyse the increasing use of stereotactic radiosurgery and the evolution of medical treatments as potential future adjuncts to surgery. The availability of multiple modalities in our armamentarium is essential in tailoring a personalised treatment approach to these patients. Owing to the multi-systemic nature of the disease, in our experience, managing the care of patients with VHL is best delivered using an interdisciplinary approach utilising multiple specialties and adopting an individually tailored holistic approach.

Keywords: Hemangioblastoma; Posterior fossa; Spinal tumours; Stereotactic radiosurgery; VHL; Von Hippel-Lindau.

Publication types

  • Review

MeSH terms

  • Central Nervous System Neoplasms* / surgery
  • Hemangioblastoma* / surgery
  • Humans
  • Spinal Cord
  • Von Hippel-Lindau Tumor Suppressor Protein


  • Von Hippel-Lindau Tumor Suppressor Protein